(Times of Israel) Shoshanna Solomon - Israel's Dune Medical Devices has developed MarginProbe, an instrument to help women with breast cancer avoid undergoing follow-up surgery to remove residual cancer cells after a tumor is removed. The device is already being used in more than 100 hospitals in the U.S. and Israel. "We have developed the only technology in the world that has a commercial product that allows surgeons in operating rooms, in real time, to check the margins of the tumor, identify cancerous tissue and decide on the spot if more tissue needs to be removed or not," said Gal Aharonowitz, general manager in charge of Israeli operations. Sensors on a hand-held probe measure the electrical properties of cells and can distinguish cancer cells from healthy ones within a second. The company is now seeking to expand the use of the device to prostate, lung and liver cancers.
2017-02-10 00:00:00Full ArticleBACK Visit the Daily Alert Archive